US$ 25.56
eli lilly's tirzepatide is the leader in weight loss sector Diabetes drug tested for could be game changer Eli Lilly's $1 Trillion Boom:
Description
Paradoxically, despite greater potency, tirzepatide's GIP component may reduce nausea compared to semaglutide at equivalent effect levels

Step 3: Start semaglutide at 0.5 mg or 1.0 mg

And can the company continue to deliver on its pipeline, from oral GLP-1s to newer mechanisms that might eventually leapfrog todays drugs
10.12688/f1000research.157194.2 59 SterneJ
:max_bytes(150000):strip_icc()/GettyImages-521503314-a3ef2646f74e4a1aa2226086dce41a42.jpg)